Recently, accumulating evidence demonstrated that the expression of NOX4 was significantly elevated in airway smooth muscle (ASM), resulting in enhanced ROS and oxidative stress in asthma patients and COPD subjects [10]. The gene discussed is NOX4; the disease is chronic obstructive pulmonary disease.